For 20 years, Tom Flynn has been an active investor in growing healthcare companies. He is currently a Managing Partner of SV Life Sciences Advisers, a healthcare and life sciences-focused investment firm with over $2 billion under management. From its offices in Boston, San Francisco and London, SV invests in biopharmaceutical, medical technology, and healthcare services companies. Flynn sits on the boards of Good Start Genetics, Health Care Essentials, Maestro Health Care Technologies, Nordic Consulting Services, Schweiger Dermatology, and Urgent Team Holdings. Prior to SVLS, Tom was a Partner at Ferrer Freeman & Co. in Greenwich, Connecticut, a private equity firm that invested exclusively in the healthcare industry. Previously, he held positions at GE Capital, Prudential Capital, and Lehman Brothers.

Flynn’s grandparents, originally from counties Cork and Kerry, immigrated to the United States prior to the Great Depression. They settled outside Boston and their children, including Flynn’s father Paul, served in two wars, became the first in their family to attend college, and achieved success in sports, business, and the law. While an undergraduate at Holy Cross College, Flynn spent his junior year at Trinity College Dublin researching his senior honors thesis, which studied the impact of microeconomic factors on the conflict in Ulster. After graduating as a Dana Scholar from Holy Cross, Flynn received his M.B.A. from Harvard Business School. He and his wife Erin live in Brookline, Massachusetts. They have three children.